Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgin A6 family-like 11, pseudogene (GOLGA6L11P) is classified as a human pseudogene on chromosome 17p13.1[3][5][7]. Pseudogenes are DNA sequences homologous to known functional genes but generally lack the ability to express a functional protein due to disabling mutations such as frameshifts or premature stop codons[8]. In most cases—including GOLGA6L11P—there is no evidence of protein expression, biological function, or disease relevance, and the locus is considered non-coding and non-functional[3][4][8]. Occasionally, pseudogenes can play regulatory roles by serving as RNA decoys or interacting with microRNAs, but there is no specific data supporting such a function for GOLGA6L11P[6][8]. This gene is not a receptor, enzyme, transporter, or canonical molecular target and is not currently associated with any known disease process or therapeutic intervention[3][8].
None (no known mechanism, as there are no drugs targeting this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgin A6 family-like 11, pseudogene (GOLGA6L11P).